Washington Trust Bank’s Precigen PGEN Stock Holding History

Washington Trust Bank’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,018	Closed	-$49K	–	1157
2016 Q2	$49K	Buy	+2,018	New	+$57.2K	0.01%	377

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Washington Trust Bank's PGEN Position: Q3 2016 in Review

Washington Trust Bank sold out of Precigen (PGEN) in Q3 2016, closing a stake of 2,018 shares — an estimated $49K sold.

Washington Trust Bank first reported a position in PGEN in Q2 2016 and held it in 1 quarter. The position peaked at $49K in Q2 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

Washington Trust Bank reported no remaining Precigen position as of Q3 2016 after selling out during the quarter.
Washington Trust Bank sold 2,018 Precigen shares in Q3 2016, an estimated $49K.
Washington Trust Bank first reported a position in Precigen in Q2 2016 and held it in 1 quarter.
Washington Trust Bank's Precigen position peaked at $49K in Q2 2016.
168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Washington Trust Bank's 13F filing for Q3 2016, filed 4 Oct 2016.